Biodesix (BDSX) Interest Expenses (2019 - 2026)

Biodesix (BDSX) has reported Interest Expenses for 8 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• Interest Expenses for Q1 2026 came in at $2.0 million, up 17.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.0 million (up 8.03% YoY), and the FY2025 annual result was $7.7 million, down 6.56% from the prior year.
• Interest Expenses was $2.0 million for Q1 2026 at Biodesix, down from $2.1 million in the prior quarter.
• Over five years, Interest Expenses peaked at $3.0 million in Q3 2022 and troughed at $1.1 million in Q1 2022.
• Average Interest Expenses over 5 years is $2.1 million, with a median of $2.1 million recorded in 2025.
• Year-over-year, Interest Expenses surged 110.29% in 2023 and plunged 33.37% in 2025.
• Over 5 years, Interest Expenses stood at $2.6 million in 2022, then dropped by 8.67% to $2.3 million in 2023, then decreased by 24.77% to $1.8 million in 2024, then climbed by 17.52% to $2.1 million in 2025, then declined by 3.98% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $2.0 million in Q1 2026, $2.1 million in Q4 2025, and $2.1 million in Q3 2025.